title: HIV-associated Kaposi's sarcoma.
abstract: Kaposi's sarcoma (KS) is a multifocal vascular tumor that occurs most commonly in patients who have immunosuppression caused by HIV. KS-associated herpes virus (human herpes virus 8, KSHV) has been identified as the causative agent. There are marked geographic differences in the prevalence of both KS and seropositivity to KSHV. The incidence of the tumor has shown a marked decline in first-world countries with the widespread use of effective antiretroviral therapy. The most effective anthracycline is pegylated liposomal doxorubicin; however, few developing countries, where KS prevalence is highest, can afford to use these agents.
authors.affiliation: Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa. sjessop@uctgsh1.uct.ac.za
authors.forename: Sue
authors.initials: S
authors.lastname: Jessop
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D003937:Diagnosis, Differential; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D012514:Sarcoma, Kaposi / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D012878:Skin Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000628:therapy